• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
Approval Date:  03/14/2008
Trade Name:  NovoLog
Generic or Proper Name (*):  insulin aspart [rDNA origin] injection
Indications Studied:  Insulin analog indicated to improve glycemic control
Therapeutic Category:  Antidiabetic
Ages Studied:  4-18 years
Study #:  1
Study Type:  Efficacy/Safety
Study Design:  Open Label/Active Control/Parallel Group
No Patients:  298
No Centers:  45
No Countries:  1